CVT-313, 98%, a potent, selective, reversible, and ATP-competitive inhibitor of CDK2,CVT-313 , 98% , 一种有效的ATP-竞争性的选择性 CDK2 抑制剂
化学品安全技术说明书(SDS)
技术规格说明书(Specifications)
质检报告 (COA)
CVT-313 , 98% , 一种有效的ATP-竞争性的选择性 CDK2 抑制剂
CVT-313, 98%, a potent, selective, reversible, and ATP-competitive inhibitor of CDK2
品牌: J&K
产品编号: 2286674
分子式: C20H28N6O3
分子量: 400.47
纯度: 98%
包装库存价格
Simple Empty
暂无数据
收藏

推荐产品

基本信息

安全信息

存储条件Freezer -20℃
Symbolimageimage
Signal WordDanger
Hazard StatementsH315 H317 H318 H334 H335 H341 H361 H370 H413
Precautionary StatementsP280 P321 P261 P272 P501 P284 P271 P319 P405 P203 P318 P260 P270 P273 P302+P352 P332+P317 P362+P364 P333+P317 P264+P265 P305+P354+P338 P304+P340 P342+P316 P403+P233 P308+P316

化学和物理性质

产品描述

产品描述

CVT-313是有效的CDK2抑制剂,在体外的IC50值为0.5 μM。它对其他非相关的、依赖于ATP的丝氨酸/苏氨酸激酶没有作用。

靶点(IC50 & Targe)

CDK1,4.2μM

CDK2,0.5μM

CDK4,215μM

体外研究

In cells exposed to CVT-313, hyperphosphorylation of the retinoblastoma gene product is inhibited, and progression through the cell cycle is arrested at the G1/S boundary. The growth of mouse, rat, and human cells in culture is also inhibited by CVT-313 with the IC50 for growth arrest ranging from 1.25 to 20 μM. CVT-313 inhibits Rb hyperphosphorylation[1].

细胞实验

Cell lines: MRC-5 cells

Concentrations: 12.5 μM

Incubation Time: 24 h

Method: --

(Only for Reference)

动物实验

Animal Models: Rat carotid artery model of restenosis

Formulation: saline

Dosages: 0.025, 0.25, 0.75, 1.25 mg/kg

Administration: intraluminal

(Only for Reference)

参考文献

[1] Brooks EE, et al. J Biol Chem. 1997, 272(46):29207-11.

参考文献